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Abstract: Thymus mastichina, also called mastic thyme or Spanish marjoram, is endemic to the Iberian
Peninsula, where it is widely used in folk medicine especially for treating digestive and respiratory
systems disorders, and as a condiment to season olives. This work describes for the first time the
detailed phenolic composition of exhaustive hydroethanolic extracts and aqueous decoctions of
Thymus mastichina. Unlike other species of the Thymus genera, Thymus mastichina extracts contain high
amounts of salvianolic acid derivatives, with salvianolic acid A isomer being the main derivative.
This isomer was identified in extracts from Thymus mastichina for the first time. Also, an undescribed
salvianolic acid derivative in Thymus mastichina was identified and its structure was tentatively
described. Extracts from Thymus mastichina showed significant scavenging activity of 2,2-azino-bis
(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical cation, hydroxyl, and nitric
oxide radicals. The anti-proliferative effect of both T. mastichina extracts were tested against Caco-2 and
HepG2 cells; the hydroethanolic extract showed a high anti-proliferative activity against Caco-2 cells
compared to HepG2 cells (at 24 h exposure, the concentration that inhibits 50% of proliferation, IC50,
was 71.18 ± 1.05 µg/mL and 264.60 ± 11.78 µg/mL for Caco-2 and HepG2, respectively). Thus, these
results make this species a promising candidate for further investigation of its anti-tumoral potential.
Therefore, Thymus mastichina can be potentially used as a functional food (used as a decoction or
herbal tea) or as a source of bioactive ingredients with antioxidant and anti-proliferative properties.
Keywords: Thymus mastichina; phenolic profiling; aqueous decoction; hydroethanolic extract;
salvianolic acid A isomer; salvianolic acid isomer B/E isomer; anti-proliferative activity; radical
scavenging activity; antioxidant
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1. Introduction
The increasing interest in phenolic compounds as natural ingredients for food additives and as
health promoters resulted in a deeper investigation of many plant species that are widely used in folk
medicine (e.g., [1–3]). Ethnobotanical surveys, particularly from the Mediterranean area, often describe
the medicinal uses of plants from the genus Thymus, a member of the Lamiaceae family, due to their high
anti-microbial [4], anti-oxidant [5,6], anti-inflammatory [7–9], and anti-proliferative [6,10–12] activities.
Some of the observed bioactivities have already been correlated with the chemical composition of the
different Thymus species, with an emphasis on various terpenoids and phenolic compounds [9,11,13,14].
Thymus mastichina (T. mastichina), also called mastic thyme, Spanish marjoram, or white thyme, is
endemic to the Iberian Peninsula where it is traditionally used for treating digestive, respiratory, and
rheumatic disorders [15–17]. Also, it is used as a condiment (e.g., to season olives and to aromatize
olive oil) and as a herbal infusion in the food industry, and as a source of essential oil in the cosmetic
and perfume industries [17,18]. Methanolic extracts of various T. mastichina samples collected in
Spain contained rosmarinic acid as the main phenolic compound and exhibited good antioxidant
activities [17,19]. The observed bioactivities may be attributed to the chemical composition of T.
mastichina. Isolated phenolic compounds of dichloromethane and ethanolic T. mastichina extracts were
tested against HCT 116 (human colorectal carcinoma) cell line, evidencing anti-tumoral activity, with
ursolic acid being the most active component [14]. In the literature, the main polyphenolic compounds
identified in T. mastichina extracts are rosmarinic acid, methoxysalicylic acid, apigenin, kaempferol,
luteolin, chlorogenic acid, caffeic acid, and derivatives of luteolin and apigenin [14,19,20]. In addition,
terpenoids, such as oleanolic and ursolic acids [14], were identified. Compared to the T. mastichina
essential oil’s composition, which is well characterized, the phenolic profile is poorly investigated and
described, as to date, there is only one study dedicated to the phenolic composition of T. mastichina,
and most of the peaks present in the chromatogram remained unidentified [17].
Further application of T. mastichina as a functional food and/or as a source of bioactive ingredients
require an extensive characterization of the phenolic composition to correlate them with potentially
claimed bioactivities. The importance of functional foods, nutraceuticals, and other natural health
products has been well recognized in connection with health promotion and disease risk reduction [21].
A nutraceutical is “a food or part of a food that provides benefits health in addition to its nutritional
content” that can be effectively used by inclusion in the daily diet as they combine both nutritional
and beneficial health properties of natural bioactive compounds. One of the main differences between
nutraceuticals and pharmaceuticals is that pharmaceuticals are usually made of one single substance
and nutraceuticals are made of a pool of substances [22]. Active substances extracted from plants
(phytocomplexes) or of animal origin, when extracted, concentrated, and administered in a suitable
pharmaceutical form, can create a very promising tool to prevent and/or support the therapy of some
pathologic conditions given their proven clinical efficacy [23]. Thus, this study aimed to characterize
the chemical composition of two T. mastichina extracts, one obtained by aqueous decoction and the
other by exhaustive hydroethanolic extraction. Furthermore, their bioactivity by in vitro antioxidant
methods as well as their anti-proliferative activity using Caco-2 (human colon adenocarcinoma cell
line) and HepG2 (human hepatocellular carcinoma cell line) cells was evaluated. These cell lines were
chosen because T. mastichina is used as condiment (aerial parts of the plant) and also as an infusion
herb. Therefore, these two cell lines mimic (as an in vitro approach) the effect of plant components’
interaction with intestinal tract tissues, the colon, during absorption and with hepatic tissues, as a
result of the first passage of absorbed components.
2. Materials and Methods
2.1. Standards and Reagents
Dulbecco’s modified eagle medium (DMEM), Trypsin-EDTA (EDTA—ethylenediaminetetraacetic
acid), sodium pyruvate penicillin, streptomycin, l-glutamine, fetal bovine serum (FBS), and
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versene were obtained from Gibco (Alfagene, Invitrogen, Portugal). Alamar Blue® was purchased
from Invitrogen, Life-Technologies (Porto, Portugal). Formic acid, acetic acid, ethanol, and
methanol were HPLC (High performance liquid chromatography) or MS (Mass Spectrometry)
grade according to the analysis and were purchased from Sigma-Aldrich/Merck (Algés, Portugal).
Commercial standards of rosmarinic acid, catechin, salvianolic acid A, salvianolic acid B, ursolic
acid, and luteolin were obtained from Sigma-Aldrich/Merck (Algés, Portugal). Oleanolic acid
was obtained from Santa Cruz Biotechnology Inc. Caffeic acid and quercetin-3-O-glucoside
were obtained from Extrasynthese® (Genay, France). Sodium nitroprusside, sulfanilamide,
N-(1-naphthyl)ethylenediamine dihydrochloride, 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic
acid) diammonium salt (ABTS), (±)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox),
potassium persulfate, Folin-Ciocalteu’s reagent, ethylenediaminetetraacetic acid (EDTA), sodium
nitrite, ascorbic acid sodium molybdate, aluminum chloride (III), thiobarbituric acid (TBA),
trichloroacetic acid (TCA), 2-deoxy-d-ribose, and hydrogen peroxide 30% solution were purchased
from Sigma-Aldrich/Merck (Algés, Portugal). Other salts and reagents not mentioned were obtained
from Sigma-Aldrich/Merck (Algés, Portugal).
2.2. Plant Material
Fresh plants were kindly supplied by ERVITAL® (Plantas Aromáticas e Medicinais, Lda; Mezio,
Portugal). Aerial parts of T. mastichina, grown in organic farming conditions were collected in October
2014. Part of the plant material served for authentication by the botanical garden office at the University
of Trás-os-Montes and Alto Douro (UTAD, Vila Real, Portugal), and a voucher specimen (Voucher N.
HVR21091) was deposited. Collected plants were rinsed with distilled water, weighted, and frozen
(−20 ◦C) upon arrival. After the lyophilization process (Dura Dry TM µP freeze-drier; −45 ◦C and
250 mTorr), the samples were properly stored until further extraction and analysis.
2.3. Preparation of Extracts
Lyophilized aerial parts of T. mastichina were ground in a blender and extracted using two
extraction methods: Aqueous decoction (AD) and hydroethanolic (HE) extraction, as detailed in [9].
Briefly, 0.5 g of freeze-dried ground plant material were used for each extraction. The decoction was
performed by adding distilled water (150 mL) to the plant material, and the suspension was heated up
to 100 ◦C under agitation and boiled for 20 min. After cooling to room temperature, the mixture was
filtered, concentrated to 100 mL (rotary evaporator, 35 ◦C), frozen, and freeze-dried. HE exhaustive
extraction was performed as three-step sequential extraction at room temperature by using 50 mL of
ethanol:water (80:20, v/v) that were added to the plant material. The mixture was agitated (orbital
shaker, 150 rpm, one hour) and then centrifuged. The supernatant was filtered and collected, then
50 mL of ethanol:water (80:20, v/v) solution was added to the pellet. After repeating the extraction
three times, the three supernatants were combined. In both extraction methods, the extracts were
filtered twice (Whatman n◦ 4 filter and fiberglass filter (1.2 µm; acquired from VWR International Ltd.,
Alfragide, Portugal)). Both extracts were concentrated in a rotary evaporator (35 ◦C). The extracts were
then lyophilized and weighed to calculate the yields.
2.4. Total Phenolic Compound, Total Flavonoid, and Ortho-Diphenol Contents
Total phenolic content (TPC) was performed according to the Folin–Ciocalteau assay, following
the method described by Machado et al. (2013) [24]. T. mastichina extract (0.1 mg/mL; 1 mL) was
mixed with 0.5 mL of Folin-Ciocalteau reagent, 1 mL of Na2CO3 (7.5%), and 7.5 mL of distilled water.
The mixture was incubated at room temperature for 1 h, and absorbance was read at 725 nm using a
spectrophotometer (PerkinElmer, Lambda 25 UV/VIS Spectrometer; Waltham, MA, USA). Caffeic acid
was used as the standard and TPC was expressed as caffeic acid equivalents (mg CA eq./g freeze-dried
plant or mg CA eq./g extract).
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Total flavonoid contents (TFC) were determined using the aluminum chloride colorimetric
method [20]. Extract solution (1 mL; 0.5 mg/mL) was incubated for 5 min with 150 µL of NaNO2 (5%),
at room temperature, followed by the addition of 150 µL AlCl3 (10%). After 6 min of incubation, 1 mL
of NaOH (1 M) was added and the absorbance was read at 510 nm. Catechin was used as the standard
and TFC was expressed as mg catechin equivalents (mg C eq./g dry plant or mg C eq./g extract).
Ortho-diphenol (ODP) contents were determined by using the sodium molybdate colorimetric
method described by Machado et al. [24]. Extracts (4 mL; 0.1 mg/mL) were mixed with 1 mL of sodium
molybdate (5%). The mixture was incubated (15 min at room temperature), and absorbance was
measured at 370 nm. Caffeic acid was used as the standard and the ODP content was expressed as mg
caffeic acid equivalents (mg CA eq./g dry plant or mg CA eq./g of extract).
2.5. Profiling and Quantification of Individual Phenolic Compounds by High Performance Liquid
Chromatography with Diode Array Detector (HPLC-DAD) and High Performance Liquid Chromatography
with Electrospray Ionization and Tandem Mass Spectrometry Detection (HPLC-ESI-MSn)
Phenolic compounds were identified by RP-HPLC-DAD and RP-HPLC-ESI-MSn. RP-HPLC-DAD
analysis was carried out using an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA) equipped
with an Ultimate 3000 pump, a WPS-3000 TSL Analyt auto-sampler, and an Ultimate 3000 column
compartment coupled to a PDA-100 photodiode array detector. A C18 column (ACE 5 C18; 250 mm ×
4.6 mm; particle size 5 µm) was used for the chromatographic separation. The temperature was held at
35 ◦C during the run and UV-Vis detection was performed between 200 and 600 nm. HPLC conditions
were used as previously described [12]. Chromeleon software (Version 7.1; Dionex, Sunnyvale, CA,
USA) was used for data acquisition, peak integration, and analysis.
LC-MSn analysis was carried out using a Thermo Scientific system equipped with a Finnigan
Surveyor Plus auto-sampler, photodiode array detector and pump, and an LXQ Linear ion trap
detector. The column used was a Luna C18 (2) (250 mm × 4.6 mm, 5 µm; Phenomenex (Aschaffenburg,
Germany)) kept at 40 ◦C. Program conditions, eluents, flow rate, and injection volume were used
as described by Taghouti et al. [12]. Electrospray ionization (ESI) was performed in negative mode
(capillary temperature: 350 ◦C; spray voltage: −4 kV; capillary voltage: −5 kV). Mass detection was
performed in the range 100–1000 m/z.
Peak identification was based on UV-VIS spectra, retention time, and mass spectra compared to
commercial standards and/or literature data. For quantification of phenolic compounds, calibration
curves of available standards were prepared [12]. When commercial standards were not available, the
quantification performed by using the aglycones or standard compounds with structural similarity.
Quercetin-(?)-O-hexoside was quantified as quercetin-3-O-hexoside; luteolin-(?)-O-hexoside and
chrysoeriol-(?)-O-hexoside were quantified as luteolin; salvianolic acid A isomer was quantified as
salvianolic acid A; salvianolic acid B/E isomer 2 was quantified as salvianolic acid B; and salvianolic
acid K and I were quantified as rosmarinic acid.
2.6. Determination of Oleanolic Acid and Ursolic Acid in Hydroethanolic Extracts
Identification and quantification of ursolic acid (UA) and oleanolic acid (OA) were performed in
HE extracts using RP-HPLC according to the method described previously by Taghouti et al. [12].
2.7. In Vitro Antioxidant Activity Assessment
2.7.1. ABTS Radical Cation Decolorization Assay
ABTS•+ scavenging assay was performed as described by Machado et al. [24]. A mixture of
equal volumes of ABTS with potassium persulfate (K2S2O8) was allowed to react for 15 to 16 h in
the dark at room temperature to produce the ABTS•+ radical. The radical solution was diluted
with acetate buffer (20 mM, pH 4.5) to obtain an absorbance of 0.700 ± 0.02 (at 734 nm). To
determine the scavenging activity of T. mastichina extracts, 200 µL of extracts (0.1 mg/mL) were
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added to 2 mL of ABTS•+ solution, and absorbance was read after 15 min at 734 nm. Trolox
((±)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) was used as a standard antioxidant
and the scavenging potential was expressed as Trolox equivalents (mmol Trolox/g dry plant or mmol
Trolox/g extract).
2.7.2. Hydroxyl Radicals Scavenging Assay
Hydroxyl radical (OH•) scavenging activity was performed as described by Taghouti et al. [12].
To 0.5 mL of extract solution (0.1 mg/mL), equal volumes (100 µL) of deoxyribose (20 mM), FeCl2 (1
mM), ascorbic acid (1 mM), H2O2 (10 mM), and 400 µL of phosphate buffer solution (20 mM; pH 7.4)
were added. A second equal sample set was prepared to contain an additional 100 µL of EDTA (1
mM). Both experimental sets were incubated 1 h at 37 ◦C. Then, 1.5 mL of TBA (thiobarbituric acid 5%
prepared in TCA (trichloroacetic acid, 10%)) was added, followed by 15 min of incubation, at 100 ◦C.
The absorbance was read at 532 nm and a blank was used as the control (same mixture as described
above, with 0.5 mL of H2O replacing the extract). The OH• scavenging activity was expressed as
percentage inhibition using Equation (1):
Inhibition (%) =
Blank abs− Sample abs
Blank abs
× 100 (1)
2.7.3. Nitric Oxide Radical Scavenging Assay
Nitric oxide radical (NO•) scavenging activity was performed as described by Sreejayan and
Rao [25]. Briefly, a solution of sodium nitroprusside (5 mM) was prepared in a phosphate buffer
(0.1 M H3PO4; pH 7.4) and was oxygenated by purging with air for 15 min. Extract solution (0.5 mL;
1 mg/mL) was added to 4.5 mL of sodium nitroprusside solution and incubated at 35 ◦C for 2 h. NO•
quantification was performed using Griess reagent (equal volumes of 1% sulfanilamide (in 5% H3PO4)
and 0.1% n-alpha-naphthyl-ethylenediamine (in water)). To 1 mL of samples (sodium nitroprusside
solution + extract), 1 mL of Griess reagent was added. After 3 min of incubation, absorbance was
measured at 546 nm. Sodium nitrite was used as the positive control. NO• scavenging activity was
expressed as the inhibition percentage; for the control (blank), H2O was used to replace the extract.
The inhibition percentage was calculated according to Equation (1).
2.8. In Vitro Cell Viability Assay
Caco-2 (human colon adenocarcinoma cell line; Cell Lines Service, Eppelheim, Germany) and
HepG2 (human hepatocellular carcinoma cell line; ATCC® Number: HB-8065TM, a gift from Prof.
C. Palmeira CNC-UC, Portugal) cells were cultured in Dulbecco’s modified eagle media (DMEM)
supplemented with 10% (v/v) fetal bovine serum (FBS), 1 mM L-glutamine, and antibiotics (100 U/mL
of penicillin and 100 µg/mL streptomycin). Cells were maintained, in a Binder incubator, at 37 ◦C in
5% CO2/95% air conditions with controlled humidity, and handled as by Severino et al. [26].
The anti-proliferative effect of extracts was performed with the Alamar Blue (resazurin) assay®
(Alfagene, Lisbon, Portugal) [27]. Resazurin is a non-toxic, water-soluble, cell-permeable redox
indicator that can be used to monitor viable cell numbers. Cellular metabolic activity results in dye
conversion from the oxidized form (resazurin; blue) into the reduced form (resorufin; pink), with
the process being accompanied by a color change. The percentage of reduced Alamar Blue can be
considered proportional to the cell viability. Briefly, cells were seeded in 96-well plates at a density
of 5 × 104 cells/mL (100 µL/well) in culture media. After 48 h of culture for cell adhesion, the culture
media was replaced with 100 µL of test solutions, prepared by dilution of respective extracts, at 10
mg/mL (stock solutions) in FBS-free DMEM to achieve the desired test solution concentrations (range
50–500 µg/mL). Cells were exposed to extracts during 24 or 48 h. After exposure, extract solutions were
removed and 100 µL of Alamar Blue solution (10% (v/v), in FBS-free culture media) were added to each
well. After 5 h of incubation, the absorbance was read at 570 (reduced form) and 620 nm (oxidized
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form) using a Multiskan EX microplate reader (MTX Labsystems, Bradenton, FL, USA). Results were
expressed as cell viability (% of control; non-treated cells), calculated as described by Andreani et
al. [27]. Control cells were submitted to all procedures but only received FBS-free DMEM, instead of
the extract, and were exposed to Alamar Blue solution simultaneously with other cells.
2.9. Statistical Analysis
Three extractions were carried out for each extraction method of extraction and analyses were
performed in triplicate. The concentration that inhibits 50% of cell viability, i.e., the IC50 values were
calculated as described by Silva et al. [28]. Analyses of variance (ANOVA) followed by Tukey’s
multiple test (α = 0.05) were performed to analyze both differences in chemical composition and
effects on cell viability. Correlations were evaluated using Pearson’s coefficient (significant if p < 0.05).
GraphPad Prism version 7 (GraphPad Software Inc, CA, USA), Microsoft Office Excel 365 (Microsoft
Corporation, WA, USA), and Statistica 12.0 (Dell Software, TE, USA) were used for graph construction
and statistical analysis.
3. Results and Discussion
3.1. Extract Yield and Chemical Composition of Extracts
In this study, two methods of extraction were selected to obtain T. mastichina extracts: The
aqueous decoction (AD) aiming to mimic the common procedure of beverage preparation for human
consumption, as this plant is also used as herbal tea, and the exhaustive hydroethanolic (HE) extraction
was chosen as a method to obtain all possible “free” phenolic compounds. In a previous work,
performing successive hydroethanolic extractions showed that 99% of the total extractable compounds
were extracted in the first three extractions [9]. As expected, the exhaustive HE procedure resulted
in higher yields than the one-step AD procedure (~14% vs. ~9% (w/w), for HE and AD, respectively,
Table 1), nevertheless, the AD method was able to extract approximately 68% of the material extracted
with exhaustive HE extraction. These results are in line with those described by Taghouti et al. [12]
for T. pulegioides and slightly lower than those obtained by Martins-Gomes et al. [9] for T. carnosus.
The exhaustive HE extraction also resulted in higher extraction yields of total phenolic compounds
(~1.96 times higher than the yield obtained by AD extraction, Table 1). The efficiency of the three-step
HE extraction in yielding higher TPC contents was observed for T. pulegioides [12] and T. carnosus [9],
too. Using different extraction conditions (50% methanol; 1 h ultra-sound bath, at room temperature),
Méndez-Tovar et al. [17] obtained a wide range of TPC contents in T. mastichina (from ~7 to ~56 mg
CA eq./g dry plant) during the characterization of 14 different wild plant populations across Spain.
The results found here (Table 1) for this species are within these values, although the extraction and
geographical origins are different. Aqueous extraction of T. mastichina grown in northern Portugal
yielded lower TPC contents (47 to 60 mg CA eq./g extract), probably due to saturation of the extraction
solution as 1 g of dry material was used per 50 mL of water. However, the extraction procedure
using other solvent mixtures (ethanol/methanol) resulted in similar TPC values (109 to 165 mg CA
eq./g extract) [16] than the ones observed here (Table 1). Methanol extracts of T. mastichina obtained
by applying the soxhlet method [19] and by repeated maceration periods [29] contained lower TPC
contents than our extracts (Table 1). The same trend was observed for the TFC and ODP contents
extracted with exhaustive HE and AD. Although the relative portions of TPC, TFC, and ODP in
the extracts obtained by HE and AD extraction from T. mastichina were similar to those found in
extracts from T. pulegioides [12] and T. carnosus [9], the absolute amount was lower, especially when
compared to T. pulegioides, where an almost double amount was extracted for both the AD and HE
extraction methods.
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Table 1. Extraction yields, chemical composition, and antioxidant activity of extracts obtained from
Thymus mastichina.
Hydroethanolic Extract Aqueous Decoction
Extraction yield (%, w/w) 13.78 ± 0.42 9.32 ± 1.74 *
Chemical composition
Total phenols (mg Caffeic
acid eq./g)
Ext. 178.89 ± 8.89 134.76 ± 2.64 *
D.P. 24.61 ± 0.67 12.51 ± 2.97 *
Total flavonoids (mg
Catechin eq./g)
Ext. 184.45 ± 5.79 195.53 ± 48.78
D.P. 25.44 ± 1.57 17.37 ± 1.14 *
Ortho-diphenols (mg
Caffeic acid eq./g)
Ext. 157.69 ± 19.34 107.87 ± 12.42 *
D.P. 21.65 ± 2.83 10.49 ± 3.06 *
CAntioxidant activity
ABTS•+ (mmol Trolox eq./g) Ext. 1.48 ± 0.06 0.96 ± 0.10 *
D.P. 0.20± 0.00 0.08±0.01 *
•OH radicals + EDTA (%
inhibition) 43.22 ± 5.28 48.52 ± 4.44
•OH radicals − EDTA (%
inhibition) 27.63 ± 2.56 28.23 ± 3.88
NO• radicals (% inhibition,
after 120 min) 38.87 ± 4.13 38.91 ± 3.01
Abbreviations: Ext.: extract. D.P.: dry plant. For antioxidant activity, percentage of inhibition obtained for 1 mg/mL
of extract. Significant statistical differences between extraction methods (*) when (p < 0.05).
3.2. Phenolic Compound Profiles in Aqueous Decoction and Hydroethanolic Extracts
The phenolic profile and the individual phenolic compounds present in the HE extract, as well as
their concentrations, are shown in Figure 1 and Table 2. Table 2 also contains the phenolic compounds
present in AD extracts and respective quantification. The relative portion of each phenolic compound
determined by HPLC-DAD is in accordance with the results obtained from the colorimetric methods
discussed above (Table 1). To the best of our knowledge, this is the first report on the detailed
phenolic composition of T. mastichina. The phenolic composition of T. mastichina extracts is comparable
to the phenolic composition previously reported in the literature for the Thymus genera [30], with
rosmarinic acid being the main phenolic compound present in both HE and AD extracts (Table 2).
Rosmarinic acid represents 34% to 40% of the total phenolic compounds extracted by the HE and
AD methods, respectively. Compared to other Thymus species, using the same extraction methods,
these portions are higher than those obtained for T. carnosus (rosmarinic acid = 6% and 20%, AD
and HE, respectively [9]) and identical to those obtained for T. pulegioides (rosmarinic acid = 35%
and 47%, AD and HE, respectively [12]). Although, when slightly different extraction methods were
used, the rosmarinic acid content (Table 2) is comparable to other T. mastichina extracts [17]. Aqueous
decoction from T. zygis, T. pulegioides, and T. fragrantissimus were composed by 52%, 36%, and 64% of
rosmarinic acid, respectively [31], and high contents in rosmarinic acid were also reported in Thymus
algeriensis [32], indicating that rosmarinic acid is a relevant phenolic compound in most Thymus species.
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Table 2. Phytochemical composition of Thymus mastichina aqueous decoction (AD) and hydroethanolic (HE) extracts determined by HPLC/DAD-ESI/MS.
Peak Number Compound R.T. (min) ESI-MS2
Quantification
HE AD Extraction
Method Sig.mg/g D.P. mg/g Extract mg/g D.P. mg/g Extract
1 Eriodictyol-di-O-hexoside 21.85 ± 0.07 [611]:449;287 n.q. n.q. n.q. n.q.
2 Naringenin-di-hexoside 22.12 ± 0.07 [595]:433;271 n.q. n.q. n.d. n.d.
3 Chlorogenic acid 23.09 ± 0.13 [353]:191;179;173;135 n.q. n.q. n.d. n.d.
4 Apigenin-(6,8)-C-diglucoside 24.63 ± 0.09 [593]:575;503;473;383 353 n.q. n.q. n.d. n.d.
5 Hydroxyjasmonicacid–hexoside 24.82 ± 0.06 [387]:369;225;207;163 n.q. n.q. n.q. n.q.
6 Caffeic acid 25.08 ± 0.10 [179]:135 n.d. n.d. 0.21 ± 0.00 2.27 ± 0.03 *
7 Eriodictyol-O-hexoside 25.65 ± 0.04 [449]:287 n.q. n.q. n.q. n.q.
8 Unknown 25.67 ± 0.04 [495]:486;451;375;368 n.d. n.d. n.q. n.q.
9 Prolithospermic acid 28.33 ± 0.04 [357]:313;269;245;203 n.d. n.d. n.q. n.q.
10 Naringenin-O-hexoside 29.19 ± 0.17 [433]:313;271;267;137 n.d. n.d. n.q. n.q.
11 Quercetin-O-hexoside 29.66 ± 0.11 [463]:301 2.80 ± 0.15 20.34 ± 1.11 0.77 ± 0.34 8.35 ± 3.69 *
12 Naringenin-O-hexoside 29.98 ± 0.62 [433]:313;271 n.q. n.q. n.q. n.q.
13 Eriodictyol-O-hexuronide 31.95 ± 0.22 [463]:287;175 n.q. n.q. n.d. n.d.
14 Luteolin-O-hexoside 32.11 ± 0.10 [447]:285 n.q. n.q. n.q. n.q.
15 Salvianolic acid F derivative 32.72 ± 0.19 [375]:313;269;179;135 n.d. n.d. n.q. n.q.
16 Quercetin-O-hexuronide 33.29 ± 0.15 [477]:301 n.q. n.q. n.d. n.d.
17 Luteolin-O-hexoside 34.18 ± 0.18 [447]:285 2.87 ± 0.56 20.85 ± 4.08 0.87 ± 0.29 9.34 ± 3.15 *
18 Unknown 35.63 ± 0.20 [523]:505;477;454;391 n.q. n.q. n.d. n.d.
19 Salvianolic acid B/E isomer 2 36.49 ± 0.37 [717]:555;519;475;357;295 2.26 ± 0.09 16.40 ± 0.65 0.7±0.14 7.49 ± 1.55 *
20 Salvianolic acid A isomer 37.33 ± 0.22 [493]:383;313;295 4.20 ± 0.42 30.47 ± 3.03 1.73 ± 0.54 18.57 ± 5.74 *
21 Luteolin-O-hexorunide 37.73 ± 0.29 [461]:285;175 n.q. n.q. n.q. n.q.
22 Rosmarinic acid 38.65 ± 0.22 [359]:223;179;161 8.00 ± 0.92 58.06 ± 6.74 3.15 ± 1.07 33.79 ± 11.48
23 Apigenin-O-hexoside 39.46 ± 0.23 [431]:269 n.q. n.q. n.q. n.q.
24 Chrysoeriol-O-hexoside 39.38 ± 0.16 [461]:299;160 n.q. n.q. n.q. n.q.
25 Salvianolic acid K 40.81 ± 0.01 [555]:537;493;359 0.57 ± 0.13 4.15 ± 0.96 0.07 ± 0.01 0.75 ± 0.07 *
26 Salvianolic acid I 41.24 ± 0.40 [537]:493;359 2.13 ± 0.14 15.44 ± 1.01 n.d. n.d. *
27 Quercetin-O-hexoside-hexuronide 42.83 ± 0.33 [639]:301 n.q. n.q. n.q. n.q.
28 Apigenin-O-hexuronide 43.59 ± 0.37 [445]:269;175 n.q. n.q. n.q. n.q.
29 Chrysoeriol-O-hexuronide 44.79 ± 0.38 [475]:299 1.05 ± 0.16 7.51 ± 1.13 0.43 ± 0.13 4.61 ± 1.35 n.s
30 Salvianolic acid K isomer 45.74 ± 0.64 [555]:493;359 n.q. n.q. n.q. n.q.
31 Luteolin 52.99 ± 0.32 [285]:241;217;199;75;151 n.q. n.q. n.q. n.q.
Total phenolic compounds 23.87 ± 1.48 173.23 ± 10.74 7.93 ± 2.52 85.17 ± 27.01 *
Total flavonoids 6.71 ± 0.87 48.71 ± 6.32 2.07 ± 0.76 22.30 ± 8.20 *
Total phenolic acids 17.16 ± 0.61 124.52 ± 4.42 5.86 ± 1.75 62.87 ± 18.81 *
AD: aqueous decoction; HE: hydroethanolic extractions; RT: retention time; ESI-MS2—Fragment ions obtained after fragmentation of the pseudo-molecular ion [M]−; n.q.: detected but not
quantified; n.d.: not detected; n.s.: not significant. Tukey’s post hoc test, significant statistical differences (*) between extraction methods, for mg/g of dry plant (D.P.), if (p < 0.05). Results
are presented as mean ± standard deviation, n = 3.
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T. mastichina extracts are composed of relatively high amounts of salvianolic acid derivatives,
including salvianolic acid K and I (only detected and not quantified in AD extract), and two isomers
of salvianolic acid A and B/E isomer 2. These salvianolic acid derivatives together account for 38%
and 32% of the total phenolic acids extracted by HE and AD extractions, respectively (Table 2). Also,
a salvianolic acid F derivative and a salvianolic acid K isomer were detected but not quantified due
to small amounts. The presence of salvianolic acid derivatives in other Thymus species has been
previously described in the literature [9,12,31–35]. Except for T. carnosus [9], and Thymus algeriensis [32],
their portion is normally represented either as <5% of the total phenolic compounds extracted [12,31]
or they could not be identified [13,17]. Salvianolic acid A isomer was identified as the main salvianolic
acid derivative in the extracts from T. mastichina. This isomer was first described in the Thymus
carnosus species [9]. In addition, another salvianolic acid isomer was detected in the extracts of T.
mastichina that eluted before salvianolic acid A isomer (Figure 1). The mass/charge (m/z) ratio of the
pseudo-molecular ion (m/z = 717) is identical to salvianolic acid B and E, and the isomer was therefore
named salvianolic acid B/E isomer 2. One isomer of salvianolic acid B/E has been previously described
in Salvia miltiorrhiza [36]. Additionally, salvianolic acid K, B (isomer 1 and 2), and I (isomer 1) have
been described in decoctions of Salvia apiana and Salvia farinacea var. Victoria Blue [37]. However,
its structure was not deduced and confirmed by further analysis. This isomer showed a retention
time higher than that of salvianolic acid B [36]; however, in our case, the retention time of the new
isomer was lower than that of salvianolic acid B (Figure 1), which in our chromatographic system
presented a retention time of 38.667 min (not shown). The salvianolic acid B/E isomer 2 represents 9.5%
and 8.8% of the total phenolic compound extracted by exhaustive HE and AD. As can be observed in
Figure 2, the ESI-MS/MS spectra of the salvianolic acid B/E isomer 2 identified in T. mastichina is clearly
different from that of salvianolic acid B and E [36,38,39]. The fragmentation scheme of salvianolic B
and E and the main ions present in MS/MS spectra, according to the literature, are shown in Figure 2D.
Also, there is a difference between the UV-Vis spectra of the salvianolic acid B/E isomer 2 and those of
salvianolic acid B standard (Figure 2C) and salvianolic acid E [38]. There is a clear difference between
the fragmentation patterns of salvianolic acid B/E isomer 2 and those of salvianolic acid B and E. The
fragment ion with m/z = 555 observed in the MS spectrum of salvianolic acid isomer 2, corresponding
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to the loss of 162 Da from the molecular ion m/z = 717, may be attributed to the loss of a caffeic acid
residue. The loss of 162 Da is absent in the MS/MS fragmentation of salvianolic acid B and E [36,39].
The main fragment ion of salvianolic acid B/E isomer 2 is observed at m/z = 519, which can be attributed
to the loss of salvianic acid (loss of 198 Da from the molecular ion with m/z = 717). This fragment ion is
also observed in the MS/MS spectra of salvianolic acids B and E, too [36,39]. The presence of caffeic
acid residue in the salvianolic acid B/E isomer 2 is also supported by the presence of the fragment ion
with m/z = 357, resulting from the loss of 162 Da from m/z = 519. This fragment ion with m/z = 357 is
only present in the MS/MS spectra of this new compound. In the MS/MS spectra of salvianolic acids B
and E, the fragment ion with m/z = 321 is observed due to the loss of 198 Da from the fragment ion at
m/z = 519. Fragment ions with m/z = 475 and m/z = 295, corresponding to the loss of 44 and 62 Da
from ions with m/z = 519 and m/z = 357, are only present in the MS/MS spectra of salvianolic acid B/E
isomer 2 when compared to the MS/MS spectra of salvianolic acids B and E. The loss of 44 Da can be
attributed to the loss of HCOOH, indicating a free carboxylic acid structure in the molecule. The loss
of 62 Da may be due to the loss of HCOOH + H2O. The additional loss of H2O (18 Da) supports the
presence of a hydroxyl group in the salvianolic acid B/E isomer 2 after the elimination of salvianic
acid and caffeic acid residues. Also, there is a significant difference between the UV-Vis spectra of the
salvianolic acid B/E isomer 2 and that of the salvianolic acid B standard (Figure 2C) and salvianolic
acid E [38], with the disappearance of the peak located at 309 nm being present as the peaks at 287 and
332 nm also present in salvianolic acids B and E, the last one as a shoulder due to peak overlapping.
Taking into account this fragmentation pattern observed for the salvianolic acid B/E isomer 2 present
in T. mastichina, and the known fragmentation pattern of other salvianolic acid derivatives already
known, the tentative structure of the salvianolic acid B/E isomer 2 is presented in Figure 2D.
Besides rosmarinic acid and salvianolic acid derivatives, the hexoside derivatives of quercetin,
luteolin, and chrysoeriol were quantified in the extracts of T. mastichina (Table 2). These flavonoids
were previously described for other Thymus species, too. The quantified flavonoids represent 28%
and 26% of the total phenolic compounds extracted by HE and AD, respectively. Luteolin hexoside,
which is probably a luteolin glucoside due to a previous report of this compound in T. mastichina
populations from Spain [17], accounted for almost 50% of the quantified flavonoids in our HE extracts
of T. mastichina. Also, other flavonoids were identified but not quantified, namely derivatives of
eriodictyol, quercetin, and luteolin (Table 2).
These results show that the phenolic profiles of the extracts from T. mastichina (Table 2) are
comparable to the phenolic profiles described in the literature for various Thymus species (e.g., [9,12,13,
40]). However, extracts from T. mastichina contain lower amounts of extractable phenolic compounds
compared to other Thymus species. In addition, two salvianolic acid isomers were quantitated in
significant amounts. The first isomer, salvianolic acid A isomer, was previously described for T.
carnosus, and the second isomer, salvianolic acid B/E isomer 2, is described here for the first time in
Thymus species.
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3.3. Oleanolic Acid and Ursolic acid Contents
Oleanolic (OA) and ursolic (UA) acids are two triterpenes that are commonly described as being
present in the alcoholic extracts from various Thymus species, for example, from T. serpyllum (3.7 and
13.9 mg/g dry plant, for OA and UA, respectively [41]) and T. carnosus (9.9 and 18.7 mg/g dry plant, for
OA and UA respectively [9]). However, these triterpenes were not detected in the HE extracts from T.
mastichina.
3.4. In Vitro Antioxidant Activity
Extracts of T. mastichina showed a significant scavenging activity of ABTS radical cation. As
expected, significantly higher scavenging activity values were obtained for the HE extracts (~1.48 mmol
Trolox eq./g extract; Table 1) compared to the AD extracts (~0.96 mmol Trolox eq./g extract, Table 1).
The values expressed as Trolox eq./g dry plant (Table 1) were lower than those found by Taghouti,
Martins-Gomes, Schafer, Felix, Santos, Bunzel, Nunes, and Silva [12] for HE and AD extracts of T.
pulegioides (0.15 and 0.34 mmol Trolox eq./g dry plant, respectively). However, they are in the same
range as those observed for the extracts of T. carnosus (0.14 and 0.21 mmol Trolox eq./g dry plant,
respectively) [9].
For the hydroxyl radical scavenging assay, both HE and AD extracts showed the same capacity
of scavenging, as an identical inhibition percentage was obtained, in both assay experiments, i.e.,
in the absence and presence of EDTA (Table 1). T. mastichina extracts (Table 1) produced a lower
inhibition percentage of the hydroxyl radical when compared to the methanolic extract of T. dacicus
methanolic [42], as the latter produced 50% of the radical scavenging at 18.85 µg/mL. However, the
inhibition percentage of T. mastichina extracts was comparable to AD extracts of T. carnosus [9] and to
HE and AD extracts of T. pulegioides [12].
For the scavenging of NO radical, both HE and AD extracts showed a similar efficiency (~40%,
Table 1). Similar values of NO radical scavenging activity were observed for the HE extracts of
T. carnosus [9] and for the HE and AD extracts of T. pulegioides [12].
The results show that, despite containing lower TPC contents (AD: 2.85 and 2.08; HE: 1.7 and
2.28 times lower than AD/HE extracts of T. carnosus [9] and T. pulegioides [12], respectively), and lower
contents of individual phenolic composition (AD: 1.95; HE: 1.83 times lower than AD/HE extracts
of T. pulegioides [12]), T. mastichina extracts still show a significant antioxidant activity, especially for
the scavenging of hydroxyl and nitric oxide radicals. This can be due to the different individual
phenolic compounds present in T. mastichina extracts or due to a higher synergism between the phenolic
compounds present in T. mastichina extracts when compared to T. carnosus and T. pulegioides extracts.
Overall, the results from these screening assays show that T. mastichina may be a potential source
of phenolic compounds with relevant antioxidant activities. In addition, decoctions, the traditional
method of consumption, extract a significant amount of the bioactive compounds when compared
to the exhaustive HE extraction (51% of TPC was obtained with AD), and show comparable radical
scavenging activities.
3.5. Anti-Proliferative Effect of T. mastichina Extracts
In order to evaluate the anti-proliferative effect of AD and HE extracts of T. mastichina, we used
the Alamar Blue (AB) reduction assay and two cell lines, HepG2 and Caco-2 (please see the methods
for details). Cells were exposed to different concentrations of T. mastichina extracts (50, 100, 200,
and 500 µg/mL) for 24 or 48 h and results were compared with control cells (non-exposed cells). As
shown in Figure 3, all the studied extracts had a dose- and time-dependent inhibitory effect on Caco-2
(Figure 3A,B) and HepG2 (Figure 3C,D) cell viability. HE extracts presented a higher anti-proliferative
activity/cytotoxicity on Caco-2 cells than the AD extracts, which correlates with its higher (almost
double) concentration of phenolic compounds (Table 2). The half-maximal inhibitory concentration
(IC50) of HE extract was statistically significantly lower than the IC50 values obtained for the AD
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extracts of T. mastichina (Figure 3E), at both time points. Caco-2 cells were more sensible to T. mastichina
extracts, compared to HepG2 cells, which is indicated by statistically significant lower IC50 values after
24 or 48 h of exposure (Figure 3E) for both extracts. In general, the IC50 values obtained after exposure
of the two cell lines to T. mastichina extracts were lower than those reported for the extracts obtained in
the same way for T. pulegioides [12], with the exception of Caco-2 at 24 h exposure to AD (T. pulegioides
AD extract IC50 in Caco-2, at 24 h, was 137.7 ± 9.82 µg/mL [12]). In addition, the IC50 values obtained
for the AD extracts from T. mastichina for both cell lines are lower than the IC50 values obtained for
AD and HE extracts from T. carnosus [9]. The lower IC50 values obtained for the HE extracts in the
HepG2 cells by Martins-Gomes et al. (2019) were attributed to the presence of significant amounts
of OA and UA [6], which were not detected in the T. mastichina HE extracts. Although extracts of
T. carnosus and T. pulegioides contain higher amounts of phenolic compounds compared to extracts from
T. mastichina, exposure of Caco-2 and HepG2 cells to HE and AD extracts from T. mastichina results
in significantly lower IC50 values compared to HE and AD extracts from T. pulegioides [12], and to
AD extracts from T. carnosus [6]. Taking into account that HE extracts from T. pulegioides only contain
1.30 mg of salvianolic acid derivative (only salvianolic acid I being present) and that salvianolic acid
derivatives are absent in the AD extract [12], the higher abundance of salvianolic acid derivatives in T.
mastichina extracts may be responsible for the higher anti-proliferative activity of T. mastichina extracts.
Wang et al. [43] observed that salvianolic acid B induced a time- and dose-dependent reduction in
HepG2 cell proliferation. At the highest concentration tested (250 µM), the cell proliferation was
reduced by 75% and 80% after 24 and 48 h of exposure, respectively [43]. In addition, salvianolic acid
B was shown to inhibit the growth of several head and neck squamous carcinoma cell lines (JHU-022
and JHU-013 cells), with an IC50 of 18 and 50 µM, respectively [44]. Also, salvianolic acid B (125
µM) was shown to reduce the cell viability of different human cell lines, in particular, liver cell lines,
Huh-7 and SK-HEP-1, to 45% and to 25% of the control [44]. Salvianolic acid A and B have been
reported as good candidates against several types of cancer as these molecules target several cell
mechanisms involved in apoptosis, cell cycle regulation, and inflammation [44–46]. As salvianolic acids
act through mechanisms that modulate various signaling pathways (e.g., Mitogen Activated Protein
Kinase (MAPK), phosphoinositide-3-kinase–protein kinase B/Akt (PI3K/PKB/Akt), nuclear factor kappa
B (NF-κB), mammalian target of rapamycin (mTOR) pathways), which are often deregulated in cancer
cells and are usually associated with drug resistance [45], plants containing these components are
potential candidates as functional foods.
Nevertheless, the nature of salvianolic acid derivatives present in the extracts can also influence the
anti-proliferative activity. T. carnosus AD extract contained 37 to 42 mg of salvianolic acid derivatives
per gram of extract, with salvianolic acid A isomer (on average 53% of salvianolic acid derivatives
extracted with AD) and salvianolic acid K (on average 41% of the salvianolic acid derivatives extracted
with AD) as main derivatives, followed by salvianolic acid A (~6%). Extracts of T. mastichina contained
lower amounts of salvianolic acid derivatives (27 mg/g of extract) compared to extracts from T. carnosus.
However, the profile of individual salvianolic acid derivatives differs from the salvianolic acid derivative
profile from T. carnosus extracts. Extracts from T. mastichina contained salvianolic acid A isomer as
the main salvianolic acid derivative (69%), followed by salvianolic acid B/E isomer 2 (27%), and
salvianolic acid K (3%), suggesting that the higher anti-proliferative activity of T. mastichina extracts
when compared to T. carnosus extracts might be due to the presence of the newly tentatively identified
salvianolic acid B/E isomer 2 (Table 2).
The American National Cancer Institute (Suffness and Pezzuto, 1990) and South-American Office
for Anti-Cancer Drug Development (Mans et al., 2000) recommend considering crude extracts with
IC50 values less than 30 to 50 µg/mL for further purification, and study, and use as functional foods.
The HE extract from T. mastichina showed an IC50 value of about 51 µg/mL in the Caco-2 cells after 48 h
(Figure 3E), and seems to be a promising source of anti-proliferative compounds against colon cancer.
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4. Conclusions
his is the first work describing the detailed phenolic composition of exhaustive hydroethanolic
and aqueous decoction extracts of T. mastichina. Among other com on phenolic compounds normally
present in Thymus species, salvianolic acid A isomer, only described earlier for T. carnosus, and another
Antioxidants 2020, 9, 34 15 of 18
salvianolic acid isomer named B/E isomer 2, described for the first time in T. mastichina and Thymus
species, were identified. Extracts of T. mastichina showed a significant scavenging activity of ABTS
radical cation, hydroxyl, and nitric oxide radicals. Both extracts, but especially HE extract, of T.
mastichina showed a high anti-proliferative activity against Caco-2 cells, suggesting T. mastichina as
an interesting candidate for further investigation concerning its anti-tumoral application either as a
functional food (used as decoction or tea) or as a source of bioactive ingredients. As T. mastichina
is an endemic species to the Iberian Peninsula, as warming and drying trends are projected for the
upcoming decades in Portugal [47,48] and Spain, the climate-driven modifications in T. mastichina
phenolic composition will be explored in future studies, using plants growing in different locations and
microclimates, so as to identify the best locations for its cultivation under current and future climates,
i.e., the locations that will maximize the beneficial properties of its extracts.
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